Infinimmune
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
$75MSeries A
Role not disclosedGC
Goldcrest Capital
Activity from announced rounds
Activity in this selectionAI · Series A
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $97M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionNorthslope
Develops mission-specific AI applications on the Palantir operating system
$22MSeries A
Role not disclosed